Department of Neuroscience, College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA.
Sci Transl Med. 2011 Nov 2;3(107):107ra109. doi: 10.1126/scitranslmed.3003062.
In human populations, cigarettes and alcohol generally serve as gateway drugs, which people use first before progressing to marijuana, cocaine, or other illicit substances. To understand the biological basis of the gateway sequence of drug use, we developed an animal model in mice and used it to study the effects of nicotine on subsequent responses to cocaine. We found that pretreatment of mice with nicotine increased the response to cocaine, as assessed by addiction-related behaviors and synaptic plasticity in the striatum, a brain region critical for addiction-related reward. Locomotor sensitization was increased by 98%, conditioned place preference was increased by 78%, and cocaine-induced reduction in long-term potentiation (LTP) was enhanced by 24%. The responses to cocaine were altered only when nicotine was administered first, and nicotine and cocaine were then administered concurrently. Reversing the order of drug administration was ineffective; cocaine had no effect on nicotine-induced behaviors and synaptic plasticity. Nicotine primed the response to cocaine by enhancing its ability to induce transcriptional activation of the FosB gene through inhibition of histone deacetylase, which caused global histone acetylation in the striatum. We tested this conclusion further and found that a histone deacetylase inhibitor simulated the actions of nicotine by priming the response to cocaine and enhancing FosB gene expression and LTP depression in the nucleus accumbens. Conversely, in a genetic mouse model characterized by reduced histone acetylation, the effects of cocaine on LTP were diminished. We achieved a similar effect by infusing a low dose of theophylline, an activator of histone deacetylase, into the nucleus accumbens. These results from mice prompted an analysis of epidemiological data, which indicated that most cocaine users initiate cocaine use after the onset of smoking and while actively still smoking, and that initiating cocaine use after smoking increases the risk of becoming dependent on cocaine, consistent with our data from mice. If our findings in mice apply to humans, a decrease in smoking rates in young people would be expected to lead to a decrease in cocaine addiction.
在人类群体中,香烟和酒精通常充当着“入门毒品”的角色,人们通常会先使用这些毒品,然后再转向大麻、可卡因或其他非法物质。为了理解药物使用的“入门序列”的生物学基础,我们在小鼠中开发了一种动物模型,并使用该模型研究了尼古丁对随后可卡因反应的影响。我们发现,用尼古丁预处理小鼠会增加可卡因的反应,如通过纹状体(与成瘾相关的奖赏的关键脑区)中的成瘾相关行为和突触可塑性来评估。运动敏化增加了 98%,条件性位置偏爱增加了 78%,可卡因诱导的长时程增强(LTP)减少增强了 24%。只有当首先给予尼古丁时,可卡因的反应才会改变,并且同时给予尼古丁和可卡因。改变药物给予的顺序是无效的;可卡因对尼古丁诱导的行为和突触可塑性没有影响。尼古丁通过抑制组蛋白去乙酰化酶增强其诱导 FosB 基因转录激活的能力,从而导致纹状体中的组蛋白整体乙酰化,从而使可卡因的反应变得敏感。我们进一步测试了这个结论,发现组蛋白去乙酰化酶抑制剂通过模拟尼古丁的作用,使可卡因的反应变得敏感,并增强伏核中的 FosB 基因表达和 LTP 抑制。相反,在一个以组蛋白乙酰化减少为特征的遗传小鼠模型中,可卡因对 LTP 的影响减弱。我们通过将低剂量茶碱(组蛋白去乙酰化酶的激活剂)注入伏核中,达到了类似的效果。这些来自小鼠的结果促使我们对流行病学数据进行了分析,结果表明,大多数可卡因使用者在开始吸烟后并且在持续吸烟时开始使用可卡因,并且在吸烟后开始使用可卡因会增加对可卡因产生依赖的风险,这与我们从小鼠中获得的数据一致。如果我们在小鼠中得到的发现适用于人类,那么年轻人吸烟率的降低预计会导致可卡因成瘾率的降低。